Success Metrics

Clinical Success Rate
91.7%

Based on 44 completed trials

Completion Rate
92%(44/48)
Active Trials
0(0%)
Results Posted
45%(20 trials)
Terminated
4(8%)

Phase Distribution

Ph phase_2
17
35%
Ph phase_1
8
17%
Ph phase_3
23
48%

Phase Distribution

8

Early Stage

17

Mid Stage

23

Late Stage

Phase Distribution48 total trials
Phase 1Safety & dosage
8(16.7%)
Phase 2Efficacy & side effects
17(35.4%)
Phase 3Large-scale testing
23(47.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

91.7%

44 of 48 finished

Non-Completion Rate

8.3%

4 ended early

Currently Active

0

trials recruiting

Total Trials

48

all time

Status Distribution
Completed(44)
Terminated(4)

Detailed Status

Completed44
Terminated4

Development Timeline

Analytics

Development Status

Total Trials
48
Active
0
Success Rate
91.7%
Most Advanced
Phase 3

Trials by Phase

Phase 18 (16.7%)
Phase 217 (35.4%)
Phase 323 (47.9%)

Trials by Status

terminated48%
completed4492%

Recent Activity

Clinical Trials (48)

Showing 20 of 48 trialsScroll for more
NCT00092729Phase 3

An Investigational Drug Study in the Treatment of Primary Dysmenorrhea (0663-064)

Completed
NCT00652301Phase 3

A Research Study to Evaluate MK0653 (Ezetimibe) and Simvastatin, Given Together and Alone, on Intestinal Absorption of Cholesterol (0653-050)(COMPLETED)

Completed
NCT00409773Phase 3

Ezetimibe/Simvastatin in Patients With Metabolic Syndrome (0653A-107)(COMPLETED)

Completed
NCT00479713Phase 3

A Study to Assess the Cholesterol Lowering Effect of an Ezetimibe/Simvastatin Combination Tablet Compared to Another Cholesterol Lowering Drug in Patients With High Cholesterol and With High Cardiovascular Risk (0653A-809)(COMPLETED)

Completed
NCT00117338Phase 3

A Study of an Intravenous Drug in Pediatric Patients With Acute Asthma (0476-301)

Completed
NCT00337675Phase 3

Intermittent and Daily Dosing for Episodic (Periodic) Asthma (0476-302)(COMPLETED)

Completed
NCT00666679Phase 2

Study of Inhaled Corticosteroid Plus Montelukast Compared With Inhaled Corticosteroid Therapy Alone in Patients With Chronic Asthma (0476-386)

Completed
NCT00664937Phase 1

Exercise Induced Bronchoconstriction (0476-359)

Completed
NCT00641771Phase 1

4-Week Study to Assess the Effect of Alendronate and Vitamin D3 Once Weekly on Fractional Calcium Absorption in Postmenopausal Osteoporotic Women (0217A-230)

Completed
NCT00834106Phase 3

Prevention of Human Papillomavirus (HPV) in 20 to 45 Year Old Chinese Women (V501-041)

Completed
NCT00090285Phase 3

An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)

Completed
NCT00679055Phase 1

A Study of How MK-0736 Affects Arterial Plaque (0736-006)(TERMINATED)

Terminated
NCT00337727Phase 3

Aprepitant for the Prevention of Chemotherapy Induced Nausea and Vomiting (CINV)(0869-130)(COMPLETED)

Completed
NCT00704132Phase 1

Sitagliptin Mechanism of Action Study in Patients With Type 2 Diabetes Mellitus (0431-059)

Completed
NCT00372060Phase 3

MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)

Completed
NCT00395343Phase 3

Sitagliptin Added-on to Insulin Study (0431-051)

Completed
NCT00060476Phase 3

Treatment With MK0966 for the Prevention of Prostate Cancer (0966-201)

Completed
NCT00048607Phase 3

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-062)(COMPLETED)

Completed
NCT00035048Phase 3

Treatment of Patients With Major Depressive Disorder With MK0869 (0869-068)(COMPLETED)

Completed
NCT00048594Phase 3

Long Term Treatment of Patients With Major Depressive Disorder With MK0869 (0869-065)(COMPLETED)

Completed

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
48